(Q80016079)
Statements
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults (English)
James L Pool
Robert Glazer
Myron Weinberger
Roxanne Alvarado
Jie Huang